same afternoon of admission were notable for Na 110 mmol/l and osmolality 351 mosm/kg (Table 2) . Her white blood cell count was 4100/ml, hemoglobin 10.6 g/dl, hematocrit 28.1%, and platelets 251 000/ml. Her serum glutamic pyruvic transaminase (SGPT) was 66 U/l, serum glutamic oxaloacetic transaminase (SGOT) 50 U/l, and albumin was 3.2 g/dl. Her uric acid level was 2.2 mg/dl. Her urinalysis had an specific gravity (SPGR) of 1.019, pH of 6.5, and was negative for leukocytes, heme, and glucose. A chest radiograph was unremarkable.
She was initially treated with intravenous normal saline with 5% dextrose for a total of 2.4 l and anti-emetics through the first 2 days of admission. With this regimen her serum sodium increased from 120 to 123 mmol/l (Table 1 and Figure 1 ), although she remained hypotensive and orthostatic. Repeat urine electrolytes were notable for Na 222 mmol/l, K 36.8 mmol/l, and osmolality 550 mosm/kg (Table 2 ). Owing to the increase in urine osmolality, she was placed on a 1 l daily fluid restriction to treat presumed syndrome of inappropriate antidiuretic hormone (SIADH). After 2 days of fluid restriction, she remained hypotensive and her serum sodium decreased to 118 mmol/l. A renal consult was then obtained on the fourth hospital day for 'refractory SIADH. ' Her vital signs at the time of renal consultation included a blood pressure of 80/61 mmHg, a heart rate of 66/min, and a temperature of 98.81F. Her physical examination was again notable for dry mucous membranes, marked skin tenting, and inability to obtain orthostatic vital signs owing to dizziness with sitting or standing. Her thyroid and adrenal function were tested and were found to be normal. Owing to prominent signs of extracellular fluid (ECF) contraction, her fluid restriction was discontinued, and she was started on a normal saline infusion at 100 ml/h (hospital day 4). Within the first 24 h of normal saline infusion, her serum sodium increased from 118 to 132 mmol/l (Table 1 and Figure 1 ), and her urine output was noted to increase from an average of 600 ml/day in the preceding 2 days to 3.6 l over the course of the next day. Her urine electrolytes, however, continued to demonstrate inappropriate natriuresis in the face of persistent hyponatremia and signs and symptoms of ECF contraction, and her serum sodium again fell after hospital day 5 when continuous IV saline infusions were stopped and sporadic IV saline boluses were administered instead (Table 1 and Figure 1 ). An magnetic resonance imaging of the brain obtained 2 days later revealed two basal frontal lobe lesions demonstrating relatively thin peripheral enhancement, most compatible with abscesses or residual/recurrent tumor ( Figure 2 ). On hospital day 10, her sodium balance was estimated to be negative by 406 mEq with a urine output of 5.8 l the preceding 24 h despite remaining hypotensive and orthostatic.
CLINICAL DIAGNOSIS
Hyponatremia secondary to cerebral salt wasting (CSW).
CLINICAL FOLLOW-UP
Her serum sodium remained exquisitely sensitive to sodium intake, predictably rising with resumption of continuous IV normal saline infusions after the diagnosis of CSW was made on hospital day 10 ( Figure 1) . In order to increase and maintain her serum sodium between 135 and 140 mmol/l, she required on average 3-3.5 l of IV normal saline and salt tablets on a daily basis to keep her total body sodium balance positive on average 275 mEq a day. A biopsy of the lesions discovered by magnetic resonance imaging revealed only necrotic tissue without any evidence of malignancy, thought possibly to be owing to infection or post-radiation changes. The scalp mesh was removed in a subsequent surgery, and she was eventually discharged 3 weeks after admission to a skilled nursing facility. Her sodium on discharge was 136, and she was discharged only on salt tablets (2 g by mouth four times a day).
DISCUSSION
CSW remains one of the most difficult causes of hyponatremia to diagnose in hospitalized patients owing to its frequent confusion with syndrome of inappropriate antidiuretic hormone (SIADH). This is because both syndromes share certain key features: low serum sodium, low serum osmolality, a higher urine osmolality than serum osmolality, and an elevated urinary sodium concentration. 1 Furthermore, the features of CSW which distinguish it from SIADH -namely extracellular fluid (ECF) contraction and inappropriately negative sodium balance -are often difficult to establish beyond a reasonable doubt, even with invasive testing or a myriad of serologic markers, further contributing to the difficulty of making this diagnosis.
2 Nevertheless, this is hardly a trivial distinction to be made, as the management of the two conditions differs markedly, and if the wrong treatment algorithm is chosen, there can be serious consequences including worsening of hyponatremia and, more rarely, cerebral ischemia. 3 The principal features of CSW generally include hyponatremia and ECF contraction owing to renal sodium wasting in the setting of intracranial disease. 4 A variety of processes have been linked with CSW, including subarachnoid hemorrhage, encephalitis, poliomyelitis, tuberculous meningitis, craniotomy, and tumors, among others. 4 In addition, a number of human and animal models of disease have consistently supported a distinct association between intracranial injury and disordered renal sodium regulation leading to volume depletion and hyponatremia. 5, 6 The mechanisms behind these associations, however, are less clear, although a number of theories have been proposed. One of the first was that CSW is a misnomer for SIADH after the first description of SIADH was published in 1957. 7 However, in several models of severe brain injury associated with the development of hyponatremia, antidiuretic hormone was found to be elevated only in the first few days after the injury was sustained, subsequently declining to normal levels in the face of prolonged and inappropriate natriuresis, suggesting that hyponatremia after the first few days of brain injury in these cases was caused by some mechanism other than abnormally elevated ADH levels. 5, 6 The observation that hyponatremia in other similar cases was successfully treated with volume resuscitation instead of fluid restriction, 8 as would be the recommended therapy in SIADH, further bolstered the case for CSW as a disorder which is distinct from SIADH. Disruptions of neuronal control of renal sodium handling have been frequently postulated to be the cause of CSW, either through the interruption of sympathetic regulation of sodium absorption, 9 or the elaboration of circulating natriuretic factors from neuronal cells. 4 Potential candidates for such factors include ouabain-like compounds; 10 atrial natriuretic peptide, which has been isolated in neurons of rats; 11, 12 and brain natriuretic peptide. [13] [14] [15] Despite a few promising studies linking some of these factors to CSW, none of them have been consistently shown to be the primary cause of renal sodium wasting and volume depletion in human or animal models of intracranial disease, making it difficult to rely on them as definitive markers of disease. As mentioned, the difficulty in conclusively diagnosing CSW rests in attempting to distinguish it from other more common causes of hyponatremia, such as SIADH or sodium depletion from non-renal causes. Much of the problem tends to arise from trying to establish that a patient is hyponatremic owing to inappropriate natriuresis (to distinguish it from non-renal sodium depletion) and that the patient is truly volume contracted (to distinguish it from SIADH). In the case presented, it was initially assumed that the patient was hyponatremic owing to non-renal sodium losses as a consequence of repeated emesis and poor oral intake in the days before admission. However, closer scrutiny of her urine electrolytes did not corroborate this initial assumption as her urine sodium was inappropriately elevated (110 mmol/l) in this setting. Normally, in the absence of sodium wasting nephropathies, severe renal impairment, defects in the renin-aldosterone axis, or diuretic treatment, her urine sodium concentration should have been much lower owing to avid compensatory sodium reabsorption in the case of extra-renal sodium depletion. 16 Furthermore, after an initial trial of volume resuscitation with normal saline, her urine sodium concentration markedly increased (Table 1) , perpetuating an inappropriate natriuresis. Importantly, the calculation of a negative sodium balance on hospital day 10 was an important clue that the natriuresis was due to abnormal renal sodium losses and was not an appropriate physiological response to intravenous volume loading. 17 Establishing that the patient is truly volume contracted is a more difficult and controversial task. The imprecision of judging ECF status by physical signs and symptoms alone is well documented. 2 Nevertheless, more invasive measures of volume, such as measuring the central venous pressure or pulmonary artery occlusion pressure, are often impractical and unwarranted, particularly in standard clinical practice, leaving physical examination findings as the most practical measures of generalized volume status available to the clinician. The patient in this case report had a variety of signs and symptoms suggesting volume contraction, which were observed by numerous examiners. Serologic markers of volume depletion, such as an increased red blood cell and plasma volume; elevated blood urea nitrogen:creatinine ratios; depressed serum urate and elevated fractional excretion of urate (X10%) after correction of the serum sodium (which some have advocated as a method to distinguish CSW from SIADH 1 ); and elevated plasma renin activity and aldosterone, have proven to be equally disappointing in serving as sensitive or specific indicators of CSW. 1 In light of this fact, we did not place a great deal of emphasis on measuring many of these factors outside of those values available through routine lab draws. Instead, the combination of physical examination signs and symptoms suggesting volume depletion, urinary sodium losses that were inappropriately elevated, hyponatremia, and radiologic imaging demonstrating cerebral lesions suggested CSW as the most likely root cause of her hyponatremia. We acknowledge that there was a discrepancy between her pulse rate and hypotension in that she never demonstrated tachycardia despite other evidence of volume contraction. This might suggest autonomic failure as one potential cause of her persistent hypotension. However, given the fact that she did not have a history of orthostatic hypotension, syncope, or pre-syncope, we felt that this was unlikely in her case. Furthermore, as hypotension owing to automonic failure is caused by decreased sympathetic nervous system activation, which itself is one potential mechanism of CSW as mentioned above, even if this were the root cause of her hypotension, her hyponatremia could still be due to CSW as decreased symphathetic input would have contributed to the urinary sodium wasting which she demonstrated. Finally, the fact that her hyponatremia worsened with fluid restriction but responded to saline volume resuscitation and oral sodium loading provided further evidence that she had this rare cause of sodium wasting.
Management of CSW includes treatment of the underlying cerebral disorder, volume resuscitation, and sodium replacement. 4 Generally, the latter two can be accomplished with intravenous isotonic saline solutions and oral salt tablets, with hypertonic saline reserved for particularly severe or refractory cases. Gradual correction of the serum sodium over several days is most safe and appropriate, especially in cases where hyponatremia has been present for an extended period of time. Enhancing renal tubular sodium absorption with mineralocorticoids such as fludrocortisone acetate can also help mitigate excessive urinary sodium losses.
Fludrocortisone has been shown to be a useful adjunct in reducing water and sodium excretion, and improving hyponatremia with less ongoing volume losses in cases of CSW. 18, 19 CSW remains a difficult diagnosis to make in hospitalized patients with hyponatremia, especially in terms of distinguishing it from other more common causes such as extrarenal sodium losses and SIADH. The key to diagnosis rests in demonstrating that hyponatremia is secondary to inappropriately high urinary sodium excretion in a patient who is volume contracted. Once the diagnosis is established, treatment includes addressing the underlying cerebral disorder, sodium loading through intravenous and oral routes, hydration, and, in some cases, administration of mineralocorticoids such as fludrocortisone acetate (Table 3) .
